Table 1.

Overview of in vivo models for assessing efficacy of antifungal drugs or treatments [references]..

Animal species	Type of infection	Candida sp.	Aspergillus sp.	Cryptococcus sp.	Other fungi
Galleria melonella (greater wax moth)		127,128,129,130,131,132,133,134,135,136,137,138,139	133,140,141,142,143,144	145,146,147,148,149	150,151,152,153,154,155
Bombyx mori (silkworm)		156	157	158,159,160
Caenorhabditis elegans		100,136,161,162,163,164,165,166,167,168,169,170,171,172,173		166,174,175	176
Drosophila melanogaster		177,178	179		180
Danio rerio Zebrafish larvae		165		145	181,182
Mice	systemic	183,184,185,186,187,188	189	190	191,192
Mice	oropharyngeal	184,193,194,195,196,197
Mice	vaginal	198,199,200,201,202
Mice	Biofilm, including dentures/keratitis	203,204,205,206,207,208
Mice	intratracheal/lung/ central nervous system		209,210,211,212,213	147,214,215,216,217	218
Mice	Cutaneous	219	220		180
Rats	Biofilm	93,101,221,222,223,224,225,226
Guinea pigs		227	228,229	230	231